Insights

Innovative Pipeline Expansion Shionogi Europe is actively developing novel therapies in areas such as antimicrobial resistance, HIV, influenza, and sleep disorders, presenting multiple opportunities to collaborate on cutting-edge clinical solutions and expand the company's drug portfolio.

Strategic Partnerships Recent collaborations with Osaka Metropolitan University and biotech firms like UBE Industries and BioVersys highlight Shionogi's openness to forming alliances, offering avenues for joint ventures, licensing, and co-marketing opportunities in specialty therapeutics.

Market Growth Activities With recent acquisitions such as Akros Pharma and a focus on extending marketed product reach, there is potential to introduce complementary medications or leverage their expansion efforts to gain footholds in European markets.

Focus on Infectious Diseases Shionogi's strategic emphasis on infectious disease solutions, including COVID-19 and sleeping disorders, indicates sales prospects within hospital and community healthcare sectors seeking innovative treatments and prophylactics.

Digital Engagement Strategy Utilizing advanced tech tools like SAS Viya, Google Tag Manager, and partnerships with platforms like LinkedIn offers sales teams opportunities to connect through targeted digital campaigns, increasing awareness and engagement with healthcare professionals and decision-makers.

Shionogi Europe Tech Stack

Shionogi Europe uses 8 technology products and services including SAS Viya, GDPR, LinkedIn, and more. Explore Shionogi Europe's tech stack below.

  • SAS Viya
    Advanced Analytics And Data Science
  • GDPR
    Certificates
  • LinkedIn
    Online Community Software
  • PHP
    Programming Languages
  • Python
    Programming Languages
  • New Relic
    Real User Monitoring
  • Google Tag Manager
    Tag Management
  • GoDaddy
    Web Hosting

Media & News

Shionogi Europe's Email Address Formats

Shionogi Europe uses at least 2 format(s):
Shionogi Europe Email FormatsExamplePercentage
First.Last@shionogi.euJohn.Doe@shionogi.eu
89%
First.Middle.Last@shionogi.euJohn.Michael.Doe@shionogi.eu
3%
F.Last@shionogi.euJ.Doe@shionogi.eu
2%
First.Middle@shionogi.euJohn.Michael@shionogi.eu
3%
First.MiddleLast@shionogi.euJohn.MichaelDoe@shionogi.eu
2%
Last@shionogi.euDoe@shionogi.eu
1%
First.Last@shionogi.comJohn.Doe@shionogi.com
66%
FLast@shionogi.comJDoe@shionogi.com
32%
FirstLast@shionogi.comJohnDoe@shionogi.com
1%
First.Middle@shionogi.comJohn.Michael@shionogi.com
1%

Frequently Asked Questions

Where is Shionogi Europe's headquarters located?

Minus sign iconPlus sign icon
Shionogi Europe's main headquarters is located at Herengracht 464, Amsterdam, North Holland 1017 BZ, NL. The company has employees across 2 continents, including EuropeAsia.

What is Shionogi Europe's phone number?

Minus sign iconPlus sign icon
You can contact Shionogi Europe's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Shionogi Europe's official website and social media links?

Minus sign iconPlus sign icon
Shionogi Europe's official website is shionogi.com and has social profiles on LinkedIn.

How much revenue does Shionogi Europe generate?

Minus sign iconPlus sign icon
As of October 2025, Shionogi Europe's annual revenue is estimated to be $73M.

What is Shionogi Europe's NAICS code?

Minus sign iconPlus sign icon
Shionogi Europe's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Shionogi Europe have currently?

Minus sign iconPlus sign icon
As of October 2025, Shionogi Europe has approximately 285 employees across 2 continents, including EuropeAsia. Key team members include Chief Executive Officer: H. T.Cfo Europe: J. J.Cmo Qa Oversight - Senior Manager: A. P.. Explore Shionogi Europe's employee directory with LeadIQ.

What industry does Shionogi Europe belong to?

Minus sign iconPlus sign icon
Shionogi Europe operates in the Pharmaceutical Manufacturing industry.

What technology does Shionogi Europe use?

Minus sign iconPlus sign icon
Shionogi Europe's tech stack includes SAS ViyaGDPRLinkedInPHPPythonNew RelicGoogle Tag ManagerGoDaddy.

What is Shionogi Europe's email format?

Minus sign iconPlus sign icon
Shionogi Europe's email format typically follows the pattern of First.Last@shionogi.eu. Find more Shionogi Europe email formats with LeadIQ.

When was Shionogi Europe founded?

Minus sign iconPlus sign icon
Shionogi Europe was founded in 2012.

Shionogi Europe

Pharmaceutical ManufacturingNetherlands201-500 Employees

Shionogi B.V. (known as “Shionogi Europe”) is the European headquarters of Shionogi & Co., Ltd, a leading global research-driven pharmaceutical company based in Osaka, Japan. Since 1878, Shionogi has been striving to supply the best possible medicines to protect the health and wellbeing of the patients we serve. 

We are dedicated to finding innovative solutions for pressing unmet clinical needs, and have a strong track record in discovering and developing novel medicines for antimicrobial resistance (AMR), HIV and influenza. Alongside our work in infectious diseases, we also have extensive expertise in other areas of unmet clinical needs within our Hospital Specialty Business, and a strong track record in other therapy areas affecting quality of life, particularly Women’s Health.

Since launching in Europe in 2012, we have significantly expanded our presence and now have coverage of the biggest markets in the continent. Our offices in Amsterdam, Berlin, London, Madrid, Paris and Rome provide the bases for over 300 passionate staff from across the spectrum of big pharma and biotech, as well as experts in technology, creatives, entrepreneurs and others - who come together to do things differently and better.

Our culture is unique, blending our Japanese roots with our strong and rapidly growing European operation. We have a friendly, inclusive work environment and aim to foster a culture that encourages our people to break out of the boundaries of the traditional pharmaceutical company. 

Through successful strategic partnerships and open collaboration, we are determined to shape the future of healthcare. Our ambitious growth plans include extending the reach of our marketed products, developing our innovative pipeline of medicines and securing the right partnerships and acquisitions to accelerate our development. 

To find out about partnering with us, visit: https://t.ly/YzlSu 

For career opportunities, visit: https://t.ly/mERcQ 

NP-EU-NP-0303 DOP July 2024

Section iconCompany Overview

Headquarters
Herengracht 464, Amsterdam, North Holland 1017 BZ, NL
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
201-500

Section iconFunding & Financials

  • $10M$25M

    Shionogi Europe's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Shionogi Europe's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.